Bayer Aktiengesellschaft (ETR:BAYN) Shares Up 1.4% - Still a Buy?

Shares of Bayer Aktiengesellschaft (ETR:BAYN - Get Free Report) shot up 1.4% during mid-day trading on Monday . The company traded as high as €19.90 ($20.95) and last traded at €19.80 ($20.84). 4,478,001 shares were traded during trading, The stock had previously closed at €19.52 ($20.55).

Bayer Aktiengesellschaft Trading Up 0.6 %

The company has a 50-day moving average price of €25.80 and a two-hundred day moving average price of €26.78. The stock has a market cap of $19.58 billion, a P/E ratio of -15.45, a P/E/G ratio of 36.39 and a beta of 0.97. The company has a current ratio of 1.27, a quick ratio of 0.72 and a debt-to-equity ratio of 129.94.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.